Evidence map›Paper›PMID 41017483›Full record

ArticleBritish journal of haematology2026

Platelet dysfunction in immune thrombocytopenia: Finding clinical subsets with platelet phenotypes.

Sidra A Ali, Sarah M Hicks, Lucy A Coupland, Simone A Brysland, Vijay Bhoopalan, Yee Lin Thong, Amandeep Kaur, Robert K Andrews, Elizabeth E Gardiner, Philip Y-I Choi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sidra A AliDivision of Genome Science and Cancer, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.ORCID https://orcid.org/0000-0001-7301-4049
Sarah M HicksDivision of Genome Science and Cancer, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.ORCID https://orcid.org/0000-0001-5712-124X
Lucy A CouplandIngham Institute for Applied Medical Research, Liverpool, New South Wales, Australia.ORCID https://orcid.org/0000-0002-8912-9534
Simone A BryslandDivision of Genome Science and Cancer, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.ORCID https://orcid.org/0000-0002-7489-812X
Vijay BhoopalanDivision of Genome Science and Cancer, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.ORCID https://orcid.org/0000-0003-3972-9256
Yee Lin ThongDivision of Genome Science and Cancer, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.ORCID https://orcid.org/0009-0008-9111-4519
Amandeep KaurDivision of Genome Science and Cancer, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.ORCID https://orcid.org/0000-0002-2382-9327
Robert K AndrewsThe National Platelet Research and Referral Centre, Canberra, Australian Capital Territory, Australia.ORCID https://orcid.org/0000-0001-9577-8082
Elizabeth E GardinerDivision of Genome Science and Cancer, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.ORCID https://orcid.org/0000-0001-9453-9688
Philip Y-I ChoiDivision of Genome Science and Cancer, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.ORCID https://orcid.org/0000-0001-9340-8125

Funding

ACT Health RIF2022001International Society on Thrombosis and Haemostasis ISTH RTWF 2019National Blood Authority NBA IgSO1National Health and Medical Research Council APP2000485National Health and Medical Research Council APP2018835
6 · The paper itself

Abstract

Patients with immune thrombocytopenia (ITP) remain a challenge to diagnose, manage and predict bleeding risk. A comprehensive assessment of platelet function may aid clinical management. This study assessed platelet parameters to predict bleeding in ITP. Blood from 103 clinically annotated cases with isolated thrombocytopenia and 123 healthy donors was evaluated. In the ITP cohort, 75/110 encounters (68%) had platelet counts below 50 × 10

Indexed as

Blood PlateletsPurpura, Thrombocytopenic, IdiopathicAdultAgedAged, 80 and overFemaleHemorrhageHumansMaleMiddle AgedPhenotypePlatelet CountYoung Adultbleedingimmune thrombocytopeniaplateletreceptorROTEM

Identifiers

PMID41017483
PMCPMC12819099

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.